Hadas Tamar Pahima, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mast Cells | 5 | 2023 | 1428 | 0.810 |
Why?
|
| Peritonitis | 1 | 2021 | 370 | 0.640 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 1434 | 0.530 |
Why?
|
| Dermatitis, Atopic | 1 | 2021 | 710 | 0.460 |
Why?
|
| Ovalbumin | 3 | 2023 | 677 | 0.260 |
Why?
|
| Staphylococcus aureus | 3 | 2023 | 1461 | 0.250 |
Why?
|
| Asthma | 2 | 2021 | 6161 | 0.250 |
Why?
|
| Eosinophils | 2 | 2021 | 946 | 0.240 |
Why?
|
| Immunoglobulin E | 4 | 2023 | 1493 | 0.210 |
Why?
|
| Cromolyn Sodium | 1 | 2022 | 77 | 0.200 |
Why?
|
| Hypersensitivity | 3 | 2021 | 1159 | 0.190 |
Why?
|
| Respiratory System Agents | 1 | 2020 | 30 | 0.180 |
Why?
|
| Inflammation | 6 | 2023 | 10747 | 0.180 |
Why?
|
| Enterotoxins | 1 | 2021 | 367 | 0.170 |
Why?
|
| Oxylipins | 1 | 2018 | 52 | 0.150 |
Why?
|
| Cyclopentanes | 1 | 2018 | 89 | 0.150 |
Why?
|
| Granulocytes | 1 | 2020 | 551 | 0.150 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2018 | 95 | 0.150 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 2 | 2018 | 34 | 0.150 |
Why?
|
| Keratosis, Actinic | 1 | 2018 | 72 | 0.150 |
Why?
|
| Immunization | 1 | 2021 | 1228 | 0.140 |
Why?
|
| Respiratory System | 1 | 2020 | 553 | 0.140 |
Why?
|
| Acetates | 1 | 2018 | 322 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 2022 | 1172 | 0.140 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2019 | 564 | 0.120 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 747 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1666 | 0.110 |
Why?
|
| Ultraviolet Rays | 1 | 2018 | 1078 | 0.110 |
Why?
|
| Animals | 10 | 2023 | 167838 | 0.080 |
Why?
|
| Protein Multimerization | 1 | 2013 | 981 | 0.070 |
Why?
|
| Mice | 7 | 2023 | 81138 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 21981 | 0.070 |
Why?
|
| Multiple Myeloma | 1 | 2022 | 5131 | 0.060 |
Why?
|
| Skin | 1 | 2018 | 4467 | 0.060 |
Why?
|
| Mitochondria | 2 | 2018 | 3600 | 0.060 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2023 | 84 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9194 | 0.050 |
Why?
|
| eIF-2 Kinase | 1 | 2022 | 144 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18110 | 0.050 |
Why?
|
| Apoptosis | 2 | 2018 | 9492 | 0.050 |
Why?
|
| Cytokines | 3 | 2021 | 7346 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 1882 | 0.040 |
Why?
|
| Calcium | 1 | 2013 | 5721 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 5796 | 0.040 |
Why?
|
| Hexokinase | 1 | 2018 | 125 | 0.040 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2020 | 663 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2021 | 1335 | 0.030 |
Why?
|
| Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2018 | 959 | 0.030 |
Why?
|
| Humans | 10 | 2023 | 759255 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13621 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 1760 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 828 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2030 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1641 | 0.030 |
Why?
|
| Calcimycin | 1 | 2013 | 213 | 0.030 |
Why?
|
| Thapsigargin | 1 | 2013 | 102 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 295 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6218 | 0.020 |
Why?
|
| Models, Animal | 1 | 2018 | 2118 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3584 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2013 | 1649 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2803 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2022 | 23362 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5903 | 0.020 |
Why?
|
| Female | 3 | 2021 | 390240 | 0.020 |
Why?
|
| Wound Healing | 1 | 2018 | 2782 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 3107 | 0.020 |
Why?
|
| Male | 2 | 2021 | 358719 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3046 | 0.020 |
Why?
|
| Cell Line | 1 | 2018 | 15636 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3724 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16532 | 0.010 |
Why?
|
| Rats | 1 | 2018 | 23694 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15815 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 87560 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 219390 | 0.000 |
Why?
|